Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Uncommon Denominator

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 26
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 22
Rounds per year 5.20
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Exits 1
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Software
  • Mobile
  • Therapeutics
  • E-Commerce
Summary

Uncommon Denominator is the famous VC, which was founded in 2018. The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Cloud Infrastructure, Health Care. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Negotiatus, Culture Biosciences, Culture Biosciences.

The overall number of key employees were 3.

The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Uncommon Denominator, startups are often financed by Y Combinator, Social Starts, Max Ventures. The meaningful sponsors for the fund in investment in the same round are Y Combinator, Verily, TJNS Capital. In the next rounds fund is usually obtained by Alumni Ventures Group, Verily, Trail Mix Ventures.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A&G Investments Iowa, United States, Webster City
CosmoCom, Inc. Melville, New York, United States
DAIICHI Aichi Prefecture, Japan, Nagoya
F. A. Sharf & Co. India, Jharkhand, Ranchi
JR Cap LLC New York, New York, United States
O.G. Tech Ventures -
Red Bull Austria, Salzburg
Sofia Capital Finland, Helsinki, Southern Finland
Vitec Group Richmond, United States, Vermont
Woori Financial Group Seoul, Seoul-t'ukpyolsi, South Korea

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kanvas Biosciences

Biotechnology
Life Science
$12M22 Jun 2023 Monmouth Junction, New Jersey, United States

Dandi Technologies

Analytics
Internet
Software
$3M13 Oct 2022 New York, New York, United States

Mytide Therapeutics

Biotechnology
Therapeutics
$7M08 Mar 2022 Boston, Massachusetts, United States

Alba Orbital

Aerospace
Satellite Communication
Space Travel
$3M14 May 2021 Glasgow, Scotland, United Kingdom

Upsie

Apps
Insurance
Mobile
Mobile Apps
Security
Software
$18M13 May 2021 Minneapolis, Minnesota, United States

Sanctuary

Digital Media
Lifestyle
Media and Entertainment
Mobile Apps
$3M10 May 2021 New York, New York, United States

Vincent

$2M08 Dec 2020 New York, United States

Kernal Biologics

Biotechnology
Pharmaceutical
Therapeutics
$2M14 Oct 2020 Cambridge, Massachusetts, United States

Allstacks

Business Intelligence
Business/Productivity Software
Machine Learning
Predictive Analytics
SaaS
Software
$4M04 Dec 2019 Raleigh, North Carolina, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Uncommon Denominator?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 26
Average round size 7M
Rounds per year 5.20
Peak activity year 2019
Lead investments 0
Follow on index 0.15
Exits 1
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Kanvas Biosciences

Biotechnology
Life Science
$12M22 Jun 2023 Monmouth Junction, New Jersey, United States

Dandi Technologies

Analytics
Internet
Software
$3M13 Oct 2022 New York, New York, United States

Mytide Therapeutics

Biotechnology
Therapeutics
$7M08 Mar 2022 Boston, Massachusetts, United States

Alba Orbital

Aerospace
Satellite Communication
Space Travel
$3M14 May 2021 Glasgow, Scotland, United Kingdom

Upsie

Apps
Insurance
Mobile
Mobile Apps
Security
Software
$18M13 May 2021 Minneapolis, Minnesota, United States

Sanctuary

Digital Media
Lifestyle
Media and Entertainment
Mobile Apps
$3M10 May 2021 New York, New York, United States

Vincent

$2M08 Dec 2020 New York, United States

Kernal Biologics

Biotechnology
Pharmaceutical
Therapeutics
$2M14 Oct 2020 Cambridge, Massachusetts, United States

Allstacks

Business Intelligence
Business/Productivity Software
Machine Learning
Predictive Analytics
SaaS
Software
$4M04 Dec 2019 Raleigh, North Carolina, United States
Crunchbase icon

Content report

The following text will be sent to our editors: